We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.47B
AUM Growth
-$8.91M
Cap. Flow
-$61.4M
Cap. Flow %
-2.48%
Top 10 Hldgs %
64.01%
Holding
148
New
9
Increased
30
Reduced
67
Closed
14

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$125M
2
SWKS icon
Skyworks Solutions
SWKS
+$88.4M
3
LW icon
Lamb Weston
LW
+$62.2M
4
PDD icon
Pinduoduo
PDD
+$41.9M
5
FLUT icon
Flutter Entertainment
FLUT
+$9.81M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$48.7M
2
MU icon
Micron Technology
MU
+$39.6M
3
ZTO icon
ZTO Express
ZTO
+$38.7M
4
BALL icon
Ball Corp
BALL
+$37M
5
ICE icon
Intercontinental Exchange
ICE
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 23.38%
2 Consumer Discretionary 15.08%
3 Energy 14.69%
4 Industrials 13.22%
5 Financials 12.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRMD icon
51
TORM
TRMD
$3.02B
$3.09M 0.13%
79,825
– –
LBPH
52
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$3.08M 0.12%
114,047
-13,001
-10% -$256K
ORCL icon
53
Oracle
ORCL
$423B
$3.07M 0.12%
21,762
– –
AMAT icon
54
Applied Materials
AMAT
$428B
$2.98M 0.12%
12,616
– –
RXRX icon
55
Recursion Pharmaceuticals
RXRX
$1.73B
$2.97M 0.12%
395,673
-1,404,796
-78% -$12.3M
LRCX icon
56
Lam Research
LRCX
$390B
$2.88M 0.12%
27,050
– –
VEEV icon
57
Veeva Systems
VEEV
$37.4B
$2.83M 0.11%
15,487
+1,873
+14% +$372K
WVE icon
58
Wave Life Sciences
WVE
$1.2B
$2.68M 0.11%
537,345
-62,810
-10% -$358K
ESPR
59
DELISTED
Esperion Therapeutics
ESPR
$2.66M 0.11%
1,196,526
-401,016
-25% -$943K
IMTX icon
60
Immatics
IMTX
$1.32B
$2.37M 0.1%
203,614
-85,075
-29% -$959K
RCUS icon
61
Arcus Biosciences
RCUS
$3.64B
$2.34M 0.09%
153,783
-50,615
-25% -$817K
ARWR icon
62
Arrowhead Research
ARWR
$12.4B
$2.3M 0.09%
88,425
-8,743
-9% -$215K
GPCR icon
63
Structure Therapeutics
GPCR
$3.78B
$2.25M 0.09%
57,230
-19,863
-26% -$816K
MRNA icon
64
Moderna
MRNA
$23.6B
$2.16M 0.09%
18,193
-5,380
-23% -$681K
ADI icon
65
Analog Devices
ADI
$190B
$2.1M 0.08%
9,196
+2,231
+32% +$476K
ANAB icon
66
AnaptysBio
ANAB
$1.68B
$2.06M 0.08%
82,401
+16,247
+25% +$378K
NXPI icon
67
NXP Semiconductors
NXPI
$60.4B
$1.85M 0.07%
6,866
– –
SRPT icon
68
Sarepta Therapeutics
SRPT
$1.77B
$1.79M 0.07%
11,301
+1,026
+10% +$132K
QCOM icon
69
Qualcomm
QCOM
$176B
$1.74M 0.07%
8,734
+2,098
+32% +$396K
TXN icon
70
Texas Instruments
TXN
$261B
$1.71M 0.07%
+8,815
New +$1.63M
ABSI icon
71
Absci
ABSI
$1.51B
$1.63M 0.07%
530,682
-245,920
-32% -$1.14M
QTTB icon
72
Q32 Bio
QTTB
$464M
$1.61M 0.07%
89,456
-20,508
-19% -$491K
LULU icon
73
lululemon athletica
LULU
$14.6B
$1.49M 0.06%
5,000
-2,000
-29% -$669K
TECH icon
74
Bio-Techne
TECH
$11.3B
$1.47M 0.06%
20,449
-2,375
-10% -$175K
MASS icon
75
908 Devices
MASS
$364M
$1.41M 0.06%
274,067
-98,233
-26% -$593K
1 2
3
4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Platinum Investment Management held 148 positions worth $2.47B, down 0.36% from $2.48B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Platinum Investment Management's Q2 2024 filing shows 9 new, 30 increased, 67 reduced and 14 closed positions. Its largest new stake was Lamb Weston: 729,393 shares worth $61.3M. The largest sale was Meta Platforms (Facebook), an estimated $48.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Platinum Investment Management's largest Q2 2024 buy was Lamb Weston: 729,393 shares worth $61.3M.
  • Platinum Investment Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $125M increase.
  • Platinum Investment Management's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $48.7M.
  • Platinum Investment Management fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $5.1M.
  • Platinum Investment Management's ten largest holdings make up 64% of its $2.47B portfolio in Q2 2024.
  • Platinum Investment Management opened 9 new positions and closed 14 in Q2 2024.
  • Platinum Investment Management's portfolio value fell 0.36% quarter-over-quarter to $2.47B.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.